Achilles Therapeutics

BiotechnologySeries CLondon, UKachillestx.com

Latest round

Series C

Last raised

Nov 2020

Total raised

$193M

Investors

8

About Achilles Therapeutics

Achilles Therapeutics Ltd, based in the UK, focuses on pioneering immuno-oncology therapies that harness the body's immune system to fight cancer.Founded in 2016 in London, UK, Achilles Therapeutics Ltd is dedicated to developing personalized cancer therapies. The company has not undergone any significant changes in business strategy. Sergio Quezada is a key founder, leading the firm as it has undertaken 5 deals since inception.Achilles Therapeutics specializes in innovative immuno-oncology therapies designed to enhance the body's ability to combat cancer. Their primary offerings focus on personalized treatments that target specific mutations within tumors, helping to tailor therapy to individual patients.25 mn.Achilles Therapeutics plans to advance its pipeline of personalized cancer therapies, with new product launches aimed for 2024. The company is targeting expansion into North American markets, specifically focusing on key treatment centers for oncology.

Who invested in Achilles Therapeutics

8 investors across 2 rounds

See all investors in Achilles Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Nov 19, 2020

    Amount

    $70M

    Investors

    Locked

  2. Series B

    Sep 3, 2019

    Amount

    $123M

    Investors

    Locked

Questions about Achilles Therapeutics

Who invested in Achilles Therapeutics?

Achilles Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Achilles Therapeutics raised?

Achilles Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Achilles Therapeutics last raise money?

Achilles Therapeutics's most recent round on record is a Series C, in Nov 2020.

What does Achilles Therapeutics do?

Achilles Therapeutics Ltd, based in the UK, focuses on pioneering immuno-oncology therapies that harness the body's immune system to fight cancer.

Where is Achilles Therapeutics headquartered?

Achilles Therapeutics is headquartered in London, UK.

Which VCs invest in companies like Achilles Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Achilles Therapeutics's stage. Their profiles are linked below.

Raising like Achilles Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.